FENNEC PHARMACEUTICALS INC.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Mar 2011 | -1,649.8% | -1,649.8% | — |
| Jun 2011 | 50.9% | 50.9% | -5.1% |
| Sep 2011 | 85.7% | 85.7% | -50.1% |
| Mar 2012 | 104.6% | 104.6% | 57.1% |
| Jun 2012 | -29.4% | -29.4% | -16.7% |
| Sep 2012 | -59.5% | -59.5% | -26.1% |
| Mar 2013 | 45.3% | 45.3% | -212.0% |
| Jun 2013 | -272.0% | -272.0% | 641.5% |
| Sep 2013 | 42.8% | 42.8% | -275.9% |
| Mar 2014 | 73.7% | 73.7% | -229.0% |
| Jun 2014 | 16.1% | 16.1% | -71.5% |
| Sep 2014 | -11.8% | -11.8% | 56.5% |
| Mar 2015 | 21.4% | 21.4% | 9.1% |
| Jun 2015 | -15.6% | -15.6% | -9.2% |
| Sep 2015 | -12.1% | -12.1% | -8.5% |
| Dec 2015 | -98.5% | -98.5% | -53.0% |
| Mar 2016 | -172.8% | -172.8% | -71.4% |
| Jun 2016 | -15.6% | -15.6% | -14.2% |
| Sep 2016 | -11.9% | -11.9% | -11.0% |
| Dec 2016 | -32.0% | -32.0% | -28.8% |
| Mar 2017 | -28.2% | -28.2% | -24.5% |
| Jun 2017 | -16.5% | -16.5% | -15.6% |
| Sep 2017 | -26.6% | -26.6% | -23.8% |
| Mar 2018 | -6.1% | -6.1% | -5.8% |
| Jun 2018 | -10.4% | -10.4% | -10.1% |
| Sep 2018 | -12.0% | -12.0% | — |
| Mar 2019 | -13.7% | -13.7% | -12.7% |
| Jun 2019 | -28.7% | -28.7% | -26.5% |
| Sep 2019 | -12.1% | -12.1% | -11.4% |
| Mar 2020 | -45.2% | -45.2% | -36.9% |
| Jun 2020 | -13.4% | -13.4% | -12.3% |
| Sep 2020 | -19.9% | -19.9% | -18.2% |
| Mar 2021 | -19.0% | -19.0% | -17.0% |
| Jun 2021 | -18.0% | -18.0% | -14.2% |
| Sep 2021 | -22.0% | -22.0% | -16.1% |
| Mar 2022 | -29.5% | -21.7% | -19.3% |
| Jun 2022 | -59.4% | -40.4% | -32.6% |
| Sep 2022 | -288.7% | -29.1% | -26.6% |
| Mar 2023 | 82.5% | -34.0% | -27.7% |
| Jun 2023 | 56.0% | -34.8% | -28.0% |
| Sep 2023 | 17.7% | -12.4% | -9.3% |
| Mar 2024 | 425.9% | 37.4% | 18.6% |
| Jun 2024 | 409.2% | -18.3% | -8.8% |
| Sep 2024 | 110.9% | -21.3% | -9.7% |
| Mar 2025 | 19.8% | -8.6% | -2.5% |
| Jun 2025 | 42.2% | -26.5% | -7.0% |
| Sep 2025 | 14.2% | -4.3% | -1.3% |
| Mar 2026 | 0.5% | 0.5% | 0.3% |
| Jun 2026 | 4.6% | 4.6% | 2.6% |